Population-based efficacy modeling of omalizumab in patients with severe allergic asthma inadequately controlled with standard therapy.

Zhu, Rui

Population-based efficacy modeling of omalizumab in patients with severe allergic asthma inadequately controlled with standard therapy. [electronic resource] - The AAPS journal Apr 2013 - 559-70 p. digital

Publication Type: Journal Article; Multicenter Study; Randomized Controlled Trial

1550-7416

10.1208/s12248-013-9463-9 doi


Adolescent
Adult
Aged
Anti-Asthmatic Agents--administration & dosage
Antibodies, Anti-Idiotypic--administration & dosage
Antibodies, Monoclonal, Humanized--administration & dosage
Asthma--diagnosis
Biomarkers--blood
Breath Tests
Child
Computer Simulation
Double-Blind Method
Drug Administration Schedule
Female
Forced Expiratory Volume
Humans
Immunoglobulin E--blood
Lung--drug effects
Male
Middle Aged
Models, Biological
Monte Carlo Method
Nitric Oxide--metabolism
Omalizumab
Prospective Studies
Spirometry
Time Factors
Treatment Outcome
Young Adult